Cover Image
市場調查報告書

肥厚性心肌症:全球臨床實驗檢討

Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 314735
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
肥厚性心肌症:全球臨床實驗檢討 Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月21日 內容資訊: 英文 58 Pages
簡介

本報告提供肥厚性心肌症相關臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,彙整地區、Phase、階段別進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 肥厚性心肌症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:心血管疾病臨床實驗的肥厚性心肌症所佔比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的成就情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與肥厚性心肌症臨床實驗的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Gilead Sciences, Inc.
    • Novartis AG
    • Heart Metabolics Ltd.
    • A. Menarini Industrie Farmaceutiche Riunite Srl
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • Johns Hopkins University
    • University of Miami
    • Brigham and Women's Hospital
    • Stanford University
    • University of Calgary
    • Johann Wolfgang Goethe University Hospitals
    • Massachusetts General Hospital
    • Duke University
    • Assistance Publique - Hopitaux de Paris

5個有代表性的臨床實驗簡介

附錄

目錄

GlobalData's clinical trial report, "Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Hypertropic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypertropic Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypertropic Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hypertropic Cardiomyopathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Hypertropic Cardiomyopathy to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hypertropic Cardiomyopathy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hypertropic Cardiomyopathy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Heart Metabolics Ltd.
      • Clinical Trial Overview of Heart Metabolics Ltd.
      • A. Menarini Industrie Farmaceutiche Riunite Srl
      • Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • University of Miami
      • Clinical Trial Overview of University of Miami
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Stanford University
      • Clinical Trial Overview of Stanford University
      • University of Calgary
      • Clinical Trial Overview of University of Calgary
      • Johann Wolfgang Goethe University Hospitals
      • Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Duke University
      • Clinical Trial Overview of Duke University
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Hypertropic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Hypertropic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hypertropic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Heart Metabolics Ltd., 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*

List of Figures

  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Hypertropic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Hypertropic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hypertropic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top